Ticker >

Astal Laboratories share price

Astal Laboratories Ltd.

BSE: 512600 SECTOR: Trading  3895   2   0

71.27
0 0
BSE: 26 Jul 04:01 PM

Price Summary

Today's High

₹ 78

Today's Low

₹ 71.27

52 Week High

₹ 79.9

52 Week Low

₹ 24

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

70.06 Cr.

Enterprise Value

64.29 Cr.

No. of Shares

0.98 Cr.

P/E

89.28

P/B

3

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  23.73

CASH

6.08 Cr.

DEBT

0.31 Cr.

Promoter Holding

19.93 %

EPS (TTM)

₹  0.8

Sales Growth

589.82%

ROE

5.51 %

ROCE

7.62%

Profit Growth

4684.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year589.82%
3 Year∞%
5 Year∞%

Profit Growth

1 Year4684.76%
3 Year407.03%
5 Year63.14%

ROE%

1 Year5.51%
3 Year1.83%
5 Year1.01%

ROCE %

1 Year7.62%
3 Year2.64%
5 Year1.51%

Debt/Equity

0.0134

Price to Cash Flow

-12.53

Interest Cover Ratio

91.55

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 19.93 0
Mar 2024 19.93 0
Dec 2023 39.79 0
Sep 2023 55.72 0
Jun 2023 61.13 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 91.55.
  • Company’s PEG ratio is 0.0487073831632394.
  • The company has an efficient Cash Conversion Cycle of 31.8804 days.
  • Company has a healthy liquidity position with current ratio of 2.0546.

 Limitations

  • Company has a poor ROE of 1.83197892086226% over the past 3 years.
  • Company has a poor ROCE of 2.63727777749829% over the past 3 years
  • Company has negative cash flow from operations of -5.5901.
  • The company has a low EBITDA margin of 0.1324% over the past 5 years.
  • The company is trading at a high PE of 89.28.
  • The company is trading at a high EV/EBITDA of 56.9937.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 3.43 1.36 1.63 8.41 12.25
Total Expenditure 3.41 1.36 1.6 7.92 11.67
Operating Profit 0.02 0 0.03 0.5 0.58
Other Income 0.09 0.01 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0.01 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.11 0.01 0.03 0.49 0.56
Tax 0.02 0 0 0 0
Profit After Tax 0.1 0.01 0.03 0.49 0.56
Adjusted EPS (Rs) 0.25 0.03 0.07 0.99 0.57

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 3.43 23.65
Total Expenditure 0.22 0.18 0.21 3.57 22.53
Operating Profit -0.22 -0.18 -0.21 -0.14 1.11
Other Income 0.2 0.2 0.21 0.18 0.01
Interest 0 0 0 0 0.01
Depreciation 0.02 0.02 0.01 0.01 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.03 0.01 -0.02 0.03 1.09
Tax 0 0 0 0.02 0.3
Net Profit -0.03 0.01 -0.02 0.02 0.78
Adjusted EPS (Rs.) -0.07 0.02 -0.04 0.04 0.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.99 3.99 3.99 3.99 9.85
Total Reserves 1.18 1.19 1.17 1.19 13.49
Borrowings 0 0 0 0 0.26
Other N/C liabilities 0 0 -0.01 0 0.01
Current liabilities 0.1 0.13 0.07 4.73 13.01
Total Liabilities 5.27 5.3 5.22 9.91 36.61
Assets
Net Block 0.07 0.05 0.01 0.01 0.69
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 5.11 3.79 9.2
Other N/C Assets 0.07 0.07 0 0 0
Current Assets 5.13 5.18 0.1 6.11 26.73
Total Assets 5.27 5.3 5.22 9.91 36.61
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.03 0.01 -0.02 0.03 1.09
Adjustment -0.19 -0.19 -0.2 -0.17 0.02
Changes in Assets & Liabilities 0.02 0 -0.04 -1.29 -6.66
Tax Paid 0 0 0 -0.01 -0.03
Operating Cash Flow -0.2 -0.19 -0.25 -1.44 -5.59
Investing Cash Flow 0.2 0.2 0.24 1.5 -6.11
Financing Cash Flow 0 0 0 0 17.69
Net Cash Flow 0.01 0.02 -0.01 0.07 5.99

Corporate Actions

Investors Details

PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
promoters 61.13 55.72 39.79 19.93 19.93
aceso research labs llp 61.13 55.72 39.79 19.93 19.93
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 38.87 44.28 60.21 80.07 80.07
ashok dama - - - 1.02 1.02
badarinarayana venkata me... - - - 1.02 1.02
bosco armando menezes - - - 1.34 1.34
emily bosco menezes - - - 1.22 1.22
gandharva financial servi... - - 2.94 1.48 1.48
gayathri radhakrishnan - - - 1.02 1.02
goondla jyothi - - - 1.02 1.02
hari kishan bhonagiri - - - 1.02 1.02
jnv suresh kumar - - - 1.02 1.02
kamalakara rao yechuri - - - 2.54 2.54
kotha vamsi prasad - - - 1.02 1.02
lekhya entertainment pvt ... - - - 3.05 3.05
lenus finvest private lim... - - - 1.02 1.02
mallikarjun gada - - - 1.02 1.02
narayana marthi venkata l... - - - 1.12 1.12
pavani vupparapalli - - 3.05 1.53 1.53
r lakshmi shobha - - 2.44 1.22 1.22
radha krishna doradla - - 4.06 3.56 3.56
ramamurty venkata bhaskar... - - - 1.53 1.53
ramaswamy anand . - - - 1.02 1.02
sana rambabu . - - 2.03 1.53 1.53
sannareddy suresh babu - - - 1.02 1.02
satyavani meduri - - - 3.56 3.56
siva nageswara rao doradl... - - 2.84 1.42 1.42
venkata padmavathi yechur... - - - 2.54 2.54
vupparapalli chandrasekha... 2.52 3.77 3.05 1.53 1.53
arati gattu - 2.01 1.62 - -
dornadula nandini - - 1.02 - -
g ravi kumar ramanadham - - 1.62 - -
gnana prakash gattu - - 1.02 - -
kamlesh natwarlal shah 2.50 2.50 1.74 - -
kanta devi samdaria - 1.40 1.13 - -
rakesh palakurthi 1.26 1.26 1.02 - -
divya kanda 1.09 1.09 - - -
gnana prakash gattu - 1.26 - - -
jainam uday shah - 1.10 - - -
pavani vupparapalli 2.52 3.77 - - -
alpa kamlesh shah 1.78 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Macro International informs about change in directorate25 May 2024, 2:26PM Astal Laboratories - Quaterly Results24 May 2024, 8:11PM Astal Laboratories - Quaterly Results24 May 2024, 8:11PM Macro International informs about disclosure 13 Feb 2024, 10:51AM Macro International - Quaterly Results9 Feb 2024, 4:06PM Macro International - Quaterly Results9 Feb 2024, 4:06PM Macro International - Quaterly Results9 Feb 2024, 4:06PM Macro International informs about disclosure 30 Nov 2023, 5:00PM Macro International informs about scrutinizer’s report20 Sep 2023, 2:41PM Macro International enters into Contrast media business25 Aug 2023, 12:47PM Macro International informs about disclosure11 Aug 2023, 1:53PM Macro International - Quaterly Results15 Jul 2023, 6:21PM Macro International - Quaterly Results15 Jul 2023, 6:21PM Macro International - Quaterly Results15 Jul 2023, 6:21PM Macro (International) Exports informs about cut- off date for e-voting24 Dec 2022, 3:30PM Macro (International) Exports informs about notice of first EGM of company 24 Dec 2022, 3:23PM Macro (International) Exports informs about newspaper publication20 Sep 2022, 4:29PM Macro International informs about disclosure16 Aug 2022, 10:09AM Macro (International) Exports informs about board meeting intimation5 Aug 2022, 4:16PM Macro (International) Exports informs about PCS certificate 14 Apr 2022, 4:35PM Macro International - Quaterly Results8 Feb 2022, 2:24PM Macro International - Quaterly Results8 Feb 2022, 2:24PM Macro International - Quaterly Results8 Feb 2022, 2:24PM Macro International informs about outcome of board meeting10 Nov 2021, 4:06PM Macro International informs about proceedings of 28th AGM27 Sep 2021, 12:30PM Macro International board to approve audited financial result22 Jun 2021, 5:11PM Macro International informs about outcome of board meeting2 Mar 2021, 4:10PM Macro International to hold board meeting24 Feb 2021, 1:15PM

Astal Laboratories Stock Price Analysis and Quick Research Report. Is Astal Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Astal Laboratories stock price today is Rs 71.27. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Astal Laboratories . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Astal Laboratories has a PE ratio of 89.2772140799198 which is high and comparatively overvalued .

  • Share Price: - The current share price of Astal Laboratories is Rs 71.27. One can use valuation calculators of ticker to know if Astal Laboratories share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Astal Laboratories has ROA of 3.3736 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Astal Laboratories has a Current ratio of 2.0546 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Astal Laboratories has a ROE of 5.5095 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Astal Laboratories has a Debt to Equity ratio of 0.0134 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Astal Laboratories has reported revenue growth of 589.8194 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Astal Laboratories for the current financial year is 4.71377766125246 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Astal Laboratories is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Astal Laboratories is Rs 0.7983 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Astal Laboratories in Ticker for free. Also, one can get the intrinsic value of Astal Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Astal Laboratories
X